点击注册小程序 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 报告摘要 政策与技术双轮驱动，百亿蓝海市场加速开启 脑机接口作为生命科学与信息技术融合的前沿领域，已从实验室走向产业化临界点。全球市场规模从2019 年12亿美元增至2023年20亿美元，2029年预计达76.3亿美元。政策端七部门联合发布《关于推动脑机接口 产业创新发展的实施意见》，明确2027年技术突破、2030年产业生态成型的目标，叠加卒中、渐冻症等刚 需驱动，行业进入"政策-研发-应用"闭环，商业化路径逐渐清晰。 临床产品有望加速落地，医疗+消费打造行业双增长曲线 医疗是目前脑机产业下游商业应用最成熟、产业规模最大的行业，2024年国内临床试验达31项，覆盖卒中 康复、意识障碍、抑郁症等10类疾病。政策端医保定价打通支付链路，有望推动脑机接口相关设备落地 ...

Group 1 - As of the end of August 2025, the total bond custody amount in China reached 174.54 trillion yuan, with a net increase of 1.51 trillion yuan month-on-month, although this was a decrease of 0.24 trillion yuan compared to the end of July [5] - The Democratic Republic of the Congo announced an extension of the cobalt export ban until October 15, 2025, transitioning to a quota system thereafter, with the country accounting for 76.3% of global cobalt production in 2024 [5] - USAC received a five-year exclusive contract from the US Department of Defense worth up to $245 million for the supply of antimony metal ingots, highlighting the strategic value of antimony [5] Group 2 - In the first eight months of 2025, the export growth rates for electric tools, hand tools, and lawn mowers were 1%, -5%, and 45% respectively, while forklifts, machine tools, and industrial sewing machines saw growth rates of 1%, 14%, and 16% respectively [7] - The export growth rates for major engineering machinery categories, including excavators, tractors, and mining machinery, were 14%, 25%, 30%, and 23% respectively [7] Group 3 - The global market size for brain-computer interfaces is expected to reach $7.63 billion by 2029, driven by policy support and demand from conditions like stroke and ALS [8] - The expected dividend yield for Gree Electric exceeded 7% in 2025, with a historical trend indicating a bottoming characteristic, supported by a projected profit of 33 billion yuan and a 52% cash dividend rate [8]

Group 1: Copper Industry - The China Nonferrous Metals Industry Association emphasizes the need to control the expansion of copper smelting capacity and is researching specific measures for standardized management [1] - Tianfeng Securities believes that the key to "anti-involution" in the copper smelting industry lies in optimizing capacity, which includes eliminating outdated capacity and enhancing efficiency through advanced smelting technologies [1] - The expectation is that the copper smelting industry will return to profitability in the long term, with improved capacity layout through supply-side reform [1] Group 2: Digital Currency - The Digital Renminbi International Operation Center has officially started operations in Shanghai, launching three major platforms: cross-border digital payment, blockchain service, and digital asset platforms [2] - Research institutions highlight that the Digital Renminbi, as a legal digital currency, utilizes advanced technologies to ensure security and stability, enhancing transaction transparency and user privacy [2] - The future development potential of Digital Renminbi is significant, presenting opportunities for technology and service companies within the industry [2] Group 3: Advanced Packaging - Intel showcased its next-generation Xeon processors at the 2025 Cloud Summit, utilizing new process technology and advanced packaging techniques to enhance performance and efficiency [3] - The advanced packaging market is expected to grow rapidly, driven by AI market demand, with a projected market size increase from $44.3 billion in 2022 to $78.6 billion by 2028, reflecting a compound annual growth rate of 10% [3] - FC packaging currently holds the largest market share at 51% in 2022, but it is expected to decrease to 47% by 2028, while 2.5D/3D packaging will see an increase from 21% to 33% [3] Group 4: AI Video Generation - Baidu has upgraded its Steam Engine model to support the generation of unlimited-length AI videos, breaking previous limitations of short video generation [4] - The new pricing strategy significantly reduces the cost of video generation, enhancing the competitiveness of Baidu's Steam Engine in the market [4] - The introduction of long video generation capabilities is expected to broaden the application scenarios for AI video generation tools, including film-level effects and digital content creation [4] Group 5: Brain-Machine Interface Technology - Qiangnao Technology has unveiled a groundbreaking wireless bionic hand that allows users to control it with their thoughts, addressing various self-care challenges for disabled individuals [5] - The product represents a shift from traditional prosthetics to a non-invasive brain-machine interface technology, enabling high-level paraplegics to perform tasks without external devices [5] - Qiangnao Technology focuses on enhancing human capabilities through non-invasive brain-machine interface technology, with plans to develop smart bionic legs in the future [5]

Market Overview - The domestic market shows significant trading activity with the Shanghai Composite Index closing at 3,853.64, up 0.83% [2] - The Shenzhen Component Index increased by 1.80%, closing at 13,356.14, while the ChiNext Index rose by 2.28% to 3,185.57 [2] Non-Bank Financial Sector - The trading activity in the non-bank financial sector has improved, with a notable increase in the average daily trading volume, which surpassed 20 trillion in August [6] - The securities transaction stamp duty reached 118.7 billion, marking an 81.7% year-on-year increase [6] - The fundamentals of brokerage firms are stabilizing and improving, with a recommendation to focus on investment opportunities in this sector [6] Biomedicine Sector - The release of the YY/T 1987-2025 standard for medical devices using brain-computer interface technology marks a significant milestone for industry standardization, expected to accelerate industrialization [7][8] - This standard aims to resolve long-standing issues of concept ambiguity and lack of standards, facilitating innovation and regulatory compliance [11] - The policy framework supporting the brain-computer interface industry is evolving, with strategic initiatives from national to local levels aimed at fostering innovation and market growth [11] Company Analysis: Fulaite (601865.SH) - Fulaite is positioned in the top tier of the photovoltaic glass industry, with expected EPS of 0.31, 0.46, and 0.84 for 2025-2027, corresponding to PE ratios of 53.9, 36.1, and 19.8 [14] - The company is anticipated to benefit from an improved supply-demand balance in the photovoltaic glass market, leading to a recovery in profitability [13][14] Company Analysis: Xianghe Industrial (603500.SH) - Xianghe Industrial reported a revenue of 3.81 billion, a year-on-year increase of 6.49%, with a net profit of 640 million, up 96.56% [20] - The company is focusing on core business areas, including rail transportation products, which have shown significant growth due to participation in major railway projects [20] - The demand for intelligent railway detection equipment is expected to grow, with the company actively developing related technologies [20]

Investment Rating - The report suggests focusing on companies with "technical barriers + clinical landing" as the dual main lines for investment, recommending attention to medical scene integrators and leaders in invasive technology [4]. Core Insights - The brain-computer interface (BCI) industry is driven by both policy and technology, with a market expected to grow from $1.2 billion in 2019 to $2 billion in 2023, and projected to reach $7.63 billion by 2029, indicating a compound annual growth rate (CAGR) of 17.5% from 2024 to 2029 [3][24]. - The medical sector is currently the most mature application area for BCI, with 31 clinical trials planned in 2024 covering various diseases, and the integration of medical and consumer applications is expected to create a dual growth curve [3][54]. - The domestic industry chain is becoming more self-sufficient, with significant advancements in invasive BCI technologies, and several regions are expected to form industrial clusters [4][27]. Summary by Sections Industry Overview - BCI technology is a frontier field at the intersection of life sciences and information technology, creating interactive systems between the brain and external devices [14][16]. - The global BCI market is projected to grow significantly, with a forecasted market size of $7.63 billion by 2029, reflecting a CAGR of 17.5% from 2024 to 2029 [24][25]. - The industry is currently in a technology validation phase, with active investment activities, particularly in China, where over 200 financing events have occurred, totaling nearly $2 billion [27][29]. Policy Guidance - The Chinese government has issued several policies to support the BCI industry, aiming for technological breakthroughs by 2027 and the establishment of a robust industrial ecosystem by 2030 [42][43]. - The regulatory framework is evolving, with ongoing efforts to ensure safety, effectiveness, and ethical compliance in BCI technology [45][47]. Clinical Situation - Stroke is identified as the primary indication for BCI applications, with a significant patient population in need of rehabilitation solutions [54][59]. - The number of clinical trials related to BCI is increasing, with 31 trials registered in 2024, indicating a growing interest in the clinical potential of BCI technologies [65][66].

Group 1: Bond Market Analysis - As of the end of August 2025, the total bond custody amount in China reached 174.54 trillion yuan, with a net increase of 1.51 trillion yuan month-on-month, which is a decrease of 0.24 trillion yuan compared to the end of July [1] Group 2: High-end Manufacturing Industry - In the first eight months of 2025, the export growth rates for electric tools, hand tools, and lawn mowers were 1%, -5%, and 45% respectively, while forklifts, machine tools, and industrial sewing machines saw growth rates of 1%, 14%, and 16% respectively [2] - The export growth rates for major engineering machinery categories such as excavators, tractors, and mining machinery were 14%, 25%, 30%, and 23% respectively [2] - The trend of declining exports to the U.S. continues, but the engineering machinery category remains in a high prosperity phase, with significant adverse impacts from tariffs on exports to North America [2] Group 3: Brain-Computer Interface Industry - The brain-computer interface market is projected to reach 7.63 billion USD by 2029, driven by policy support and demand from conditions like stroke and ALS [3] - A joint policy from seven departments outlines development goals for the industry, creating a "policy-research-application" closed loop, with a clearer commercialization path [3] - Recommended companies to watch include Xiangyu Medical, Weisi Medical, Chengyitong, Mailande, Aipeng Medical, and Sanbo Brain Science [3]

本报记者 郭冀川 9月23日，在第25届中国国际工业博览会开幕式上，工业和信息化部党组书记、部长李乐成表示，工业 是物质生产的基本力量，在生产力构成中处于主体和支柱地位，是发展新质生产力的主战场、主阵 地。"十四五"以来，中国推进新型工业化取得历史性成就，制造业增加值达33.6万亿元，总体规模连续 15年保持全球第一，预计"十四五"期间中国制造业增加值增量达8万亿元，对全球制造业增长贡献率超 过30%。 北京邮电大学区块链与人工智能联合实验室执行主任陈晓华对《证券日报》记者表示，培育新兴产业、 前瞻布局未来产业，是推动经济高质量发展、构建现代化产业体系的关键战略。无论是人工智能、生物 医药等新兴产业，还是量子科技、脑机接口等未来产业，都具备高技术含量、高附加值的鲜明特征，它 们不仅能够创造新的经济增长点，还能推动经济结构优化升级，提升经济发展的质量和效益。 当前，人工智能、高端制造与新材料的深度融合，正催生以人形机器人、脑机接口为代表的新一代颠覆 性产品，这些产品市场前景广阔、发展潜力巨大。在不久前举办的2025世界机器人大会上，展示了机器 人产业的最新发展成果。同时，大会还达成了融资金额14.81亿元，为机 ...

Core Insights - Brain-computer interfaces (BCIs) are emerging as a critical technology for information exchange between the brain and external devices, with significant applications in medical rehabilitation and human-machine collaboration, positioning them as a strategic focal point in global technological competition [1][2] - Shanghai has been intensively developing the BCI sector since 2025, with initiatives such as the "Shanghai Brain-Computer Interface Future Industry Cultivation Action Plan (2025-2030)" and the establishment of the "Brain Intelligence World" industrial cluster [1][3] - The Siniang Incubator, a key player in this cluster, aims to support innovation, clinical transformation, and acceleration in the BCI field, marking a shift from traditional incubation models to a more integrated approach involving investment and professional services [5][6] Industry Development - The BCI industry is still in its infancy globally, with most companies engaged in exploratory technology development and concept validation, creating opportunities for Chinese enterprises to leapfrog traditional development paths [3][4] - The Siniang Incubator is focusing on creating a concept validation platform to support early-stage research and development, targeting not only registered startups but also teams with technological potential that have not yet formed companies [4][6] Funding and Support - The Siniang Incubator collaborates with various funds to provide financial support, including the Siniang Fund, which has already invested in several BCI companies [6][8] - Policy incentives are also in place, offering substantial subsidies for research and development, which can significantly enhance the financial viability of startups in the BCI sector [6][8] Collaborative Ecosystem - The Siniang Incubator is building a comprehensive service model that addresses the unique challenges faced by cross-disciplinary companies in the BCI field, providing support from research to clinical trials [7][8] - The incubator's location within the "Brain Intelligence World" cluster allows for close collaboration with leading medical institutions, enhancing the clinical application of BCI technologies [8][9] Clinical Integration - Partnerships with top medical institutions like Huashan Hospital facilitate access to extensive clinical data and expertise, which are crucial for the development and validation of BCI technologies [9][10] - The integration of clinical, research, and production capabilities within the incubator's ecosystem is expected to accelerate the transition of BCI technologies from laboratory settings to clinical applications [10][11]

Investment Rating - The report maintains an investment rating of "Leading the Market-A" for the biopharmaceutical industry, indicating an expected price increase exceeding the benchmark index by more than 10% [10]. Core Insights - The biopharmaceutical industry has shown significant market performance over the past year, with innovations in drug development, particularly in the area of cancer therapies such as PD-1 and ADCs [2]. - The release of the YY/T 1987-2025 standard for brain-computer interface (BCI) medical devices marks a critical step in the industrialization of BCI technology in China, addressing long-standing issues of concept ambiguity and standardization [3][4]. - The establishment of a unified terminology system is expected to enhance communication between research, clinical applications, and regulatory bodies, thereby improving the efficiency of technology transfer [3]. - The report highlights the ongoing policy evolution in the BCI sector, characterized by national strategic guidance, industry collaboration, and localized implementation efforts [4][6]. Summary by Sections Industry Performance - The biopharmaceutical sector has experienced notable advancements, particularly in innovative drug therapies for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) [2]. Policy Developments - The introduction of the BCI terminology standard is part of a broader policy framework aimed at fostering the development of the BCI industry, which has been recognized as a strategic priority since the launch of the China Brain Project in 2016 [3][4]. Technological Innovations - Recent breakthroughs in BCI technology, such as the "NeuroWorm" developed by the Shenzhen Institute of Advanced Technology, demonstrate China's leading position in implantable BCI solutions, with applications in treating neurological disorders [6]. Investment Recommendations - The report suggests focusing on companies involved in BCI technology, including Chengyitong, Xiangyu Medical, Aipeng Medical, Weisi Medical, Mcland, and Xinwei Medical, as potential investment opportunities [7].

Core Viewpoint - The brain-computer interface (BCI) technology is entering a rapid development phase as it begins clinical trials, but there are concerns about the shortage of high-end research talent in China, which may hinder progress in the field [1][2]. Group 1: Talent Shortage and Development - The shortage of high-end research talent and insufficient support for young researchers are significant issues that may restrict breakthroughs in brain science [2][4]. - Companies like Brain Tiger Technology are actively contributing to talent cultivation by donating to educational institutions, emphasizing the importance of academic foundations for industry innovation [2][3]. - The Chinese government has issued opinions to strengthen talent training in relevant disciplines and encourage collaboration between enterprises and educational institutions to cultivate interdisciplinary talents [2][4]. Group 2: Interdisciplinary Approach - The BCI field requires a diverse skill set, including knowledge of neuroscience, engineering, and algorithms, which presents a high knowledge barrier for talent development [4][5]. - Experts suggest that companies should invest resources in establishing joint laboratories and talent training programs with universities to secure BCI talent [4][5]. - The development of BCI technology is seen as crucial for technological advancement, industrial upgrading, and improving human life quality, highlighting the need for interdisciplinary composite talents [4][5]. Group 3: Educational Initiatives - Hainan University is implementing a cross-disciplinary talent training program that aligns with the needs of the BCI industry, focusing on interdisciplinary integration [5]. - The university promotes innovative talent cultivation models, such as academic mentorship and personalized training plans, to enhance students' practical and innovative capabilities [5].